Dr. Jeffrey Clark Klein is a Project Manager at Harrington Discovery Institute (HDI). Jeff provides project management support to Harrington Scholars and the Therapeutic Development Team to efficiently advance therapeutic assets toward clinical use.
Jeff joined HDI in October 2019. Prior to joining HDI, Jeff spent 10 years in positions that focused on the commercial translation of early-stage therapeutics, including in academic technology transfer (Case Western Reserve University and the Johns Hopkins University), government technology transfer (the National Institutes of Health), and small biotech (NovelMed Therapeutics). In his positions within academic and government technology transfer, Jeff led and supported various internal translational funding programs, including the use of nondilutive funding sourced by the federal government, state government, and a foundation, as well as an equity-based mechanism for Case Western Reserve University startups.
Jeff received his PhD from the Johns Hopkins University. His thesis focused on HIV-1 gp120 drug and vaccine design and he was a core contributor to a fully funded, multi-institutional, translationally-focused project. He received his MBA from Case Western Reserve University’s Weatherhead School of Management. He is also a Registered Patent Agent.